Drug Information

General Information
Drug ID
DR00017
Drug Name
Tiotropium
Synonyms
(1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide; (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide; 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; BA 679 BR; BA 679BR; BA-679 BR; BA-679-BR; Spiriva; Spiriva (TN); Spiriva Handihaler; Spiriva Respimat; TIOTROPIUM BROMIDE; Tiotropium bromide [USAN:INN]
Drug Type
Small molecular drug
Indication Chronic obstructive pulmonary disease [ICD11: CA22] Approved [1]
Therapeutic Class
Bronchodilator Agents
Structure
3D MOL 2D MOL
Formula
C19H22NO4S2+
Canonical SMILES
C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
InChI
InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17+
InChIKey
LERNTVKEWCAPOY-FPISHFTHSA-N
CAS Number
CAS 186691-13-4
Pharmaceutical Properties Molecular Weight 392.5 Topological Polar Surface Area 116
Heavy Atom Count 26 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 6
XLogP
2.3
PubChem CID
5487427
PubChem SID
134356992 , 135200496 , 135651266 , 140035980 , 140036001 , 172914590 , 175268858 , 176484519 , 176485044 , 176485084 , 180123694 , 180371973 , 223404197 , 223404198 , 223573677 , 230569065 , 242495157 , 242656157 , 244840198 , 249309736 , 252166793 , 39473136 , 50113015 , 51387641 , 58832470
ChEBI ID
CHEBI:90960
TTD Drug ID
D0P1WA
DT(s) Transporting This Drug OCT-1 Transporter Info Organic cation transporter 1 Substrate [2]
OCTN2 Transporter Info Organic cation/carnitine transporter 2 Substrate [3]
References
1 Tiotropium was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42.
3 Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. Mol Pharm. 2010 Feb 1;7(1):187-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.